3569952301INDUSTRIALIZACAO EFET.P/CONTA E ORDEM / INDUSTRIALIZACAO EF55114266912023-02-22T10:10:17-03:00123522208119110900GRC10.060831658002110BOEHRINGER INGELHEIM DO BRASIL QUIMICA e FARMACEUTICA LTDABOEHRINGER INGELHEIM DO BRASILRod. Regis Bittencourt (BR116)S/NKm 286Jardim Itapecerica3522208Itapecerica da SerraSP068887001058Brasil551121087200370010071119102633711305161069000544BRAINFARMA INDUSTRIA QUIMICA E FARMACEUTICA S.A.V PR - 1S/NDISTRITO AGROINDUSTRIAL DE ANAPOLIS5201108ANAPOLISGO751320201058Brasil11450720301102063796000000000000183931SEM GTINBUSCODUO FCT 10500 mg BULK HYPERA3004499013001010006124PC760848.00000.058671994944640.47SEM GTINPC760848.00000.05867199491E75347760848.0002023-01-182023-04-18500344640.477.00003124.83999510606-LT: E75347 -Dt.Prod: 18/01/2023 -Dt.Valid: 18/04/2023 -QT: 760.848 / Resolucao do Senado Federal no 13/12, Numero da FCI . / BU: Saude Consumidor000000000010000511SEM GTINCELULOSE MICROCAviPH102 09371391290310006124KG2.268037.896825396885.95SEM GTINKG2.268037.89682539681D379992.2682021-02-282025-02-27200385.954.00003.44999510606-LT: D37999 -Dt.Prod: 28/02/2021 -Dt.Valid: 27/02/2025 -QT: 2,268000000000010000511SEM GTINCELULOSE MICROCAviPH102 09371391290310006124KG3.780037.8968253968143.25SEM GTINKG3.780037.89682539681D439573.7802021-04-152025-04-142003143.254.00005.73999510606-LT: D43957 -Dt.Prod: 15/04/2021 -Dt.Valid: 14/04/2025 -QT: 3,780000000000010000511SEM GTINCELULOSE MICROCAviPH102 09371391290310006124KG89.950037.89583101723408.73SEM GTINKG89.950037.89583101721E3721789.9502021-07-112025-07-1020033408.734.0000136.35999510606-LT: E37217 -Dt.Prod: 11/07/2021 -Dt.Valid: 10/07/2025 -QT: 89,950000000000010000551SEM GTINESTEARATO MAGNESIO VEGET03577291570390006124KG3.296024.614684466081.13SEM GTINKG3.296024.61468446601E523803.2962021-05-292026-05-29200381.134.00003.25999510606-LT: E52380 -Dt.Prod: 29/05/2021 -Dt.Valid: 29/05/2026 -QT: 3,296 / BU: Producao Farmacos000000000010000554SEM GTINALCOOL ISOPROP PA ESP 00476 PFPCEX290512200006124KG0.208030.43269230776.33SEM GTINKG0.208030.43269230771E408580.2082018-11-262023-11-3020036.334.00000.25999510606-LT: E40858 -Dt.Prod: 26/11/2018 -Dt.Valid: 30/11/2023 -QT: 0,208 / BU: Producao Farmacos000000000010000602SEM GTINEUDRAGIT NE 30 D390690190006124KG7.420063.1037735849468.23SEM GTINKG7.420063.10377358491E407837.4202021-03-012023-03-012003468.234.000018.73999510606-LT: E40783 -Dt.Prod: 01/03/2021 -Dt.Valid: 01/03/2023 -QT: 7,420 / BU: Producao Farmacos000000000010000611SEM GTINTALCO 08264252620000006124KG7.90203.978739559631.44SEM GTINKG7.90203.97873955961E371137.9022021-09-112026-09-11000331.447.00002.20999510606-LT: E37113 -Dt.Prod: 11/09/2021 -Dt.Valid: 11/09/2026 -QT: 7,902 / BU: Producao Farmacos000000000010000619SEM GTINCARMELOSE SODICA BLANVER 0177391231110006124KG32.9600120.36559466023967.25SEM GTINKG32.9600120.36559466021E3950932.9602021-09-272023-09-2700033967.257.0000277.71999510606-LT: E39509 -Dt.Prod: 27/09/2021 -Dt.Valid: 27/09/2023 -QT: 32,960000000000010000647SEM GTINSILICONE ANTIESP S184391000120006124G23.00000.436521739110.04SEM GTING23.00000.43652173911D0791023.0002020-11-172023-11-30100310.044.00000.40999510606-LT: D07910 -Dt.Prod: 17/11/2020 -Dt.Valid: 30/11/2023 -QT: 23,000 / BU: Producao Farmacos000000000010000669SEM GTINHIPROMELOSE E 5 PR 04736391239100006124KG1.9740199.4427558257393.70SEM GTINKG1.9740199.44275582571E450741.9742021-09-192026-09-180003393.707.000027.56999510606Producao Farmacos -LT: E45074 -Dt.Prod: 19/09/2021 -Dt.Valid: 18/09/2026 -QT: 1,974 / BU:000000000010000704SEM GTINDIOXIDO DE SILICIO 200 09428281122900006124KG3.295041.5902883156137.04SEM GTINKG3.295041.59028831561E370933.2952021-11-112023-11-100003137.047.00009.59999510606-LT: E37093 -Dt.Prod: 11/11/2021 -Dt.Valid: 10/11/2023 -QT: 3,295 / BU: Outras Atividades000000000010000705SEM GTINMACROGOL 6000 05474340420100006124KG2.468016.790923825041.44SEM GTINKG2.468016.79092382501E251432.4682022-04-062024-04-06200341.444.00001.66999510606-LT: E25143 -Dt.Prod: 06/04/2022 -Dt.Valid: 06/04/2024 -QT: 2,468 / BU: Producao Farmacos000000000010000738SEM GTINDIOXIDO DE TITANIO 03108282300100006124KG2.710031.800738007486.18SEM GTINKG2.710031.80073800741E428432.7102021-03-212026-03-21200386.184.00003.45999510606-LT: E42843 -Dt.Prod: 21/03/2021 -Dt.Valid: 21/03/2026 -QT: 2,710 / BU: Producao Farmacos000000000010001862SEM GTINPARACETAMOL COMPAP L Malinkrod PFPCEX300390550006124KG397.352087.729167086134859.36SEM GTINKG397.352087.72916708611E33138397.3522021-08-182023-08-18200334859.364.00001394.37999510606-LT: E33138 -Dt.Prod: 18/08/2021 -Dt.Valid: 18/08/2023 -QT: 397,352 / BU: Outras Atividades000000000010001862SEM GTINPARACETAMOL COMPAP L Malinkrod PFPCEX300390550006124KG54.840087.72921225384811.07SEM GTINKG54.840087.72921225381C4962254.8402020-06-152025-06-1520034811.074.0000192.44999510606-LT: C49622 -Dt.Prod: 15/06/2020 -Dt.Valid: 15/06/2025 -QT: 54,840 / BU: Outras Atividades000000000010001862SEM GTINPARACETAMOL COMPAP L Malinkrod PFPCEX300390550006124KG5.700087.7298245614500.06SEM GTINKG5.700087.72982456141D440775.7002021-06-022023-06-022003500.064.000020.00999510606-LT: D44077 -Dt.Prod: 02/06/2021 -Dt.Valid: 02/06/2023 -QT: 5,700 / BU: Outras Atividades000000000075000360SEM GTINETIQUETA AD CX PD BRANCA RDC71305 x100482190000006124PC11.00000.12727272731.40SEM GTINPC11.00000.12727272731E2749211.0002022-07-012023-07-0100031.407.00000.10999510606-LT: E27492 -Dt.Prod: 01/07/2022 -Dt.Valid: 01/07/2023 -QT: 11 / BU: Producao Farmacos000000000075001394SEM GTINFITA PRETA 110X450MM 2511 CIMJET300ZE500961210000006124G4.38100.19401963020.85SEM GTING4.38100.19401963021E815994.3812023-01-232025-02-0700030.857.00000.06999510606-LT: E81599 -Dt.Prod: 23/01/2023 -Dt.Valid: 07/02/2025 -QT: 4,381 / BU: Outras Atividades000000000010018228SEM GTINBUTILBROMETO DE ESCOPOLAMINA HYPERA293979110006902KG8.24004574.509708737937693.96SEM GTINKG8.24004574.50970873791E494288.2402021-09-222026-09-2265010855490.000.00000.00490.000.00000.00-LT: E49428 -Dt.Prod: 22/09/2021 -Dt.Valid: 22/09/2026 -QT: 8,240 / BU: Producao Farmacos93673.925222.120.000.000.000.000.000.00131367.880.000.000.000.000.000.000.000.000.00131367.88157695405000109TRANS-WAR-TRANSPORTES LTDA244296671112AV RICARDO BASSOLI CEZARE 3850CAMPINASSP2PaleteBOEHRINGER673.000720.0000000426691131367.880.00131367.880012023-04-23131367.881593673.92PF 492-3 OSASCOICMS SUSPENSO CFE. ART. 402 DO RICMS/00 // IPI SUSPENSO CF. ART. 43 INC.VI DEC.7212/10HYg0edpZKDZJuiH6bTGILhgQBYI=Rkx3NEJ6vCai3BvrxCvo6wHqBGNP1+H+H9eqqk+a0K+8N2LHqyAZUU/D6kC+z9aUfg9Quogpen66 l3u2oTwdtu7gCJt/VC4JKan/gQh/vQBmYHOM/4l6glbTOBJPFXrjTfFleKShV64SX0aosvG1loLt BQkovpP+4qg3IFfJLYLrfjOWykmtyg/ZvnU/XZhZsx617MINlfzEGaDXcTI7owscYKagi4ZquHhC atxZ2G/23/0JGbmZk6niQnyC6LRgVOutZKMI58FCogamjQVm9JIsIV2hp6AgN7pkihZsyLCmZYFY O43kI7fvFyFOAKb/sXOUOIgPYFIJDduLN4yjig==MIIHyzCCBbOgAwIBAgIINzC2nCwnlT4wDQYJKoZIhvcNAQELBQAwTDELMAkGA1UEBhMCQlIxEzAR BgNVBAoMCklDUC1CcmFzaWwxKDAmBgNVBAMMH1NFUkFTQSBDZXJ0aWZpY2Fkb3JhIERpZ2l0YWwg djUwHhcNMjIxMDIwMTcyMDAwWhcNMjMxMDIwMTcxOTU5WjCCAQQxCzAJBgNVBAYTAkJSMRMwEQYD VQQKDApJQ1AtQnJhc2lsMRQwEgYDVQQLDAsoRU0gQlJBTkNPKTEUMBIGA1UECwwLKEVNIEJSQU5D TykxFDASBgNVBAsMCyhFTSBCUkFOQ08pMSUwIwYDVQQLDBxTRVJBU0EgQ2VydGlmaWNhZG9yYSBE aWdpdGFsMRcwFQYDVQQLDA42MjE3MzYyMDAwMDE4MDEZMBcGA1UECwwQVklERU9DT05GRVJFTkNJ QTFDMEEGA1UEAww6Qk9FSFJJTkdFUiBJTkdFTEhFSU0gRE8gQlJBU0lMIFFVSU1JQ0EgRSBGQVJN QUNFVVRJQ0EgTFREQTCCASIwDQYJKoZIhvcNAQEBBQADggEPADCCAQoCggEBALYofw1W/qAtikAz ld8L/bgqMXlBEXUSTh52Yhbk9mqC1yv0gV+RjQ9sZOEUZri9kml7u9ea1IM74TsU4uTBERNR1A92 005ytDE8BNow3Bpl8azeIQErfH3nRf8zaJwPQ8k7Ohzz5702rL+hwCsoVw4XQ67qiqkbMUfn8kEa bopnNcmOZ2xLCZ7dyqlT83JFkEH27NXSBS+Oic+Wi1pNRSzo/9dK2KJ2+MMQKMW7yQyD/8D4oJTB xguZ2E1zIqqiBqt0lWWPEu9nXyH+yRL+h8J0XWsfwFJ0DkNOpT5Ww0YW8+4Kp2E8aqN4F3rDDlUW QYtrozBCnNM0oLQfCR6CieUCAwEAAaOCAvUwggLxMB8GA1UdIwQYMBaAFFZ1r0pzstgIxH37bCgc EdX3wajMMIGXBggrBgEFBQcBAQSBijCBhzBHBggrBgEFBQcwAoY7aHR0cDovL3d3dy5jZXJ0aWZp Y2Fkb2RpZ2l0YWwuY29tLmJyL2NhZGVpYXMvc2VyYXNhY2R2NS5wN2IwPAYIKwYBBQUHMAGGMGh0 dHA6Ly9vY3NwLmNlcnRpZmljYWRvZGlnaXRhbC5jb20uYnIvc2VyYXNhY2R2NTCB1AYDVR0RBIHM MIHJgS9DQURBU1RST1RSSUJVVEFSSU8uSVRBQEJPRUhSSU5HRVItSU5HRUxIRUlNLkNPTaA+BgVg TAEDBKA1EzMxNzAyMTk4MDI4MjY3NzA5ODUxMDAwMDAwMDAwMDAwMDAwMDAwMDAwMDAwMDAwMDAw MDCgIgYFYEwBAwKgGRMXRkVMSVBFIFRIT01BWiBERSBBUVVJTk+gGQYFYEwBAwOgEBMONjA4MzE2 NTgwMDAxNzegFwYFYEwBAwegDhMMMDAwMDAwMDAwMDAwMHEGA1UdIARqMGgwZgYGYEwBAgEGMFww WgYIKwYBBQUHAgEWTmh0dHA6Ly9wdWJsaWNhY2FvLmNlcnRpZmljYWRvZGlnaXRhbC5jb20uYnIv cmVwb3NpdG9yaW8vZHBjL2RlY2xhcmFjYW8tc2NkLnBkZjAdBgNVHSUEFjAUBggrBgEFBQcDAgYI KwYBBQUHAwQwgZsGA1UdHwSBkzCBkDBJoEegRYZDaHR0cDovL3d3dy5jZXJ0aWZpY2Fkb2RpZ2l0 YWwuY29tLmJyL3JlcG9zaXRvcmlvL2xjci9zZXJhc2FjZHY1LmNybDBDoEGgP4Y9aHR0cDovL2xj ci5jZXJ0aWZpY2Fkb3MuY29tLmJyL3JlcG9zaXRvcmlvL2xjci9zZXJhc2FjZHY1LmNybDAdBgNV HQ4EFgQU6ZTneXS6FRlWXIySQhY+jZqhDp8wDgYDVR0PAQH/BAQDAgXgMA0GCSqGSIb3DQEBCwUA A4ICAQAAaTeHwHdceje5jgt/8ABexAKFkXPgtKfD5CqKDb7RkKrDrrYyBOF/lAX5jvwGAy728/Ec /pbPhKhFoOeK6jOKWn/+YxQxZSNk54AOpkmNymd9FlqXb1hjIgMNiQZN1DuGqMbwhSrGum855u5e EqjGGZdYiNL/KhIPBkIaz7mycvM6dS14I4lyMR89tB2NjIckfeGZ47KAbQY+XbHpmsSoNNPWXQsR JALbp2Mg3iLGXi+5Ho69kppdZc1eVpYEEXiP7pXAEjhGTtn4EYPzu2teT1G4LRHb8jkOK+7pvtnK F1EzmcdnIA6mAdTqgilny/nM44LqLvIrbF+xpbtRlJdiKDf8uO9qs87zre3uo4WbdWj8e1JcXnJm +T+1XTNpR+l4EJer2tveZM287rb/mtnoKAZLW6sAyjUQMzmpxlFNbKES2NvInM1al5L7vel5ggn5 PtiBVKzfB0PttDEWanvwR1edOxv0FGlBJ5kCenooi9tpHlIfpznG6ZSt5KqOFC3o24FsaSHGqrsK 8X8cc/i7W3454DmT66b3m3QHb393Z8OcE3YoE4Xvyf3eMp5owcHbMJQZzvUszsvZE641jf0j4tWz eklyJuSrsW8UCQoCzjIuPuQP7XychaFZcBRSo9b8aQ0YFB+sasNLeUSCUytFfgcalsZT1WNxYQdF Jtfjtw==1SP_NFE_PL009_V4352302608316580021105501100042669116995230192023-02-23T10:11:04-03:00135230281392726HYg0edpZKDZJuiH6bTGILhgQBYI=100Autorizado o uso da NF-e